Schedule 13G ownership disclosure
Abeona Therapeutics Inc
Common Stock, $0.01 par value · CUSIP: 00289Y206
Event date: 2024-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nantahala Capital Management, LLC
Shares: 4,426,382.00 · Class: 9.9900%
- Wilmot B. Harkey
Shares: 4,426,382.00 · Class: 9.9900%
- Daniel Mack
Shares: 4,426,382.00 · Class: 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-119142
- Form type
- SCHEDULE 13G/A
- Filer
- ABEONA THERAPEUTICS INC.
- CIK
- CIK 318306
- Filed
- Nov 14, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership